Dr Reddy

Pharma major Dr Reddy's Laboratories today beat Street estimates by reporting a 77% on-year jump in December quarter profit after tax at Rs 1,247 crore. Its revenue jumped 27% YoY to Rs…

New Delhi: The semi annual rebalance of S&P BSE Sensex is scheduled for Friday, December 16. This will be in effect from Monday, December 19. The rebalance of the benchmark index happens…

Nifty futures on the Singapore Exchange traded 41 points, or 0.22 per cent higher at 18,865.5, signaling that Dalal Street was headed for a positive start on Monday. Here are a dozen stocks…

Stock exchange BSE today announced that auto major Tata Motors will replace pharma stock Dr Reddy's Laboratories in Sensex from next month. With effect from December 19, Dr Reddy's will not…

Nifty futures on the Singapore Exchange traded 41.5 points, or 0.28 per cent higher at 16,981.5, signaling that Dalal Street was headed for a positive start on Wednesday. Here are a dozen…

Nifty futures on the Singapore Exchange traded 242.5 points, or 1.43 per cent higher at 17,110.5, signaling that Dalal Street was headed for a positive start on Tuesday. Here are a dozen…

…

In FY23, the company is targeting 130 drug launches in the emerging markets, of which 30 would be in India.SynopsisFor Sun Pharma, its investment in speciality business is paying off, as it…

Pune: Relief for Sputnik beneficiaries seeking a booster shot is finally in sight.A spokesperson of Dr Reddy's, which distributes Sputnik V in India, told TOI on Thursday that it expected…

A press release from the drug maker said Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia, following its…